SEO URLwww.firestrike.ai/deals/takeda-pharmaceutical-company-orifarm-acquisition-2026
acquisitionAnnounced · Mar 9, 2026parallel importingSource · Community DiscussionsArticle · Expectations
Orifarm acquires Takeda Pharmaceutical Company
David Najork · Founding Software Engineer
Published · Updated · 1 min read
Deal value
—
Target
Takeda Pharmaceutical Company
NYSE: TAK · Tokyo, Tokyo
Acquirer
Orifarm
Full Acquisition
Status
—
Orifarm agreed to acquire Takeda Pharmaceutical Company. Reported deal value: Undisclosed. Status: Announced. Sector: parallel importing. Target headquarters context: Tokyo, Tokyo, Japan.
This page summarizes publicly available information about the transaction as of 2026-03-09. Figures and status may change as filings and press coverage update.
Read more in our Subscription Orifarm boss sets his sights on new acquisitions in Europe after learning lessons from Takeda The acquisition from Takeda back in 2021 was too big a bite for the Danish parallel importer
Deal timeline
Announced
Mar 9, 2026 · medwatch.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in parallel importing. Figures and status may change as sources update.
Sources: medwatch.com · Primary article · FireStrike proprietary index